Publications by authors named "Emil Bik"

Claim this Profile
D
Dual pattern of immune-related hepatotoxicity induced by pembrolizumab: hepatitis and sclerosing cholangitis.
Emil Bik, Paweł Piluch, Artur Kośnik, Anna Stadnik, Jakub Grzybowski

Pol Arch Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine carcinoma of the extrahepatic bile duct in a patient with primary sclerosing cholangitis: a rare and unexpected diagnosis.
Jan Domański, Magdalena Papież, Artur Kośnik, Emil Bik, Jakub Grzybowski

Pol Arch Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study.
Maria Arechederra, Emil Bik, Carla Rojo, Jasmin Elurbide, María Elizalde

Liver Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis.
Jeremy S Nayagam, Tobias J Weismüller, Piotr Milkiewicz, Karolina M Wronka, Emil Bik

JHEP Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of pregnancy in patients with primary sclerosing cholangitis.
Karolina M Wronka, Emil Bik, Piotr Milkiewicz

Dig Liver Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma.
Karolina Maria Wronka, Michał Grąt, Jan Stypułkowski, Emil Bik, Waldemar Patkowski

J Clin Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial.
Michał Grąt, Karolina M Wronka, Zbigniew Lewandowski, Karolina Grąt, Maciej Krasnodębski, Emil Bik

Clin Nutr· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.
Michał Grąt, Jan Stypułkowski, Waldemar Patkowski, Karolina M Wronka, Emil Bik

Ann Surg Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Transplantation Outcomes in Recipients with High Model for End-Stage Liver Disease (MELD) Scores: The Relevance of MELD Scores.
Karolina Maria Wronka, Michał Grąt, Jan Stypułkowski, Emil Bik, Maciej Krasnodębski

Ann Transplant· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.
Michał Grąt, Karolina M Wronka, Jan Stypułkowski, Emil Bik, Maciej Krasnodębski

Ann Surg Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.
Michał Grąt, Jan Stypułkowski, Waldemar Patkowski, Emil Bik, Maciej Krasnodębski

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis